Value-based care (VBC) is a popular topic across healthcare. A lot is being said, but what does it all mean? And how important is it in oncology specifically? With increased payer activity and diverse provider perspectives and incentives, VBC is a complex topic that we sought to unwind and investigate for our valued subscribers.
In December, we released our annual special topic report centered on VBC in oncology from a private-payer perspective. Our key questions include:
VBC ideally seeks to align payers’ and providers’ interests by moving away from incentivizing high volume, high cost care
Head over to our subscriber portal to check out our latest extrospections about VBC in oncology. You can find this report under the “Special Report” tab, titled “2022 Special Topic Report – Oncology Value-based Care Private Payers”.
As always, please reach out with any comments or questions you have.
All the best...
-- HMP Market Access Insights Team
Welcome to the August 2023 edition of our Monthly Insight Series. This month we take a deeper look into independent community oncology practices’ evolving interest in joining oncology network aggregators.
Taylor CrutisonCMMI has launched its new oncology pilot, the Enhancing Oncology Model, sparking questions about its new features vs the Oncology Care Model, the benefits and concerns for participating practices, and CMMI’s ability to successfully implement the program.
Taylor CrutisonWelcome to the July 2023 edition of our Monthly Insights Series. This month we want to share some more thoughts on opportunities for manufacturer engagement with IDN stakeholders—the IDN pharmacy/pharmacists, in particular.
Cindy Chen